Search
for
Sort by
Research 901–930 of 1000+
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Human Placenta Extract (HPH) Suppresses Inflammatory Responses in TNF-α/IFN-γ-Stimulated HaCaT Cells and a DNCB Atopic Dermatitis (AD)-Like Mouse Model
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Effects of the α-ketoglutaric acid on the performance, hair follicle development and antioxidant capacity of Rex rabbits
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study
- Melatonin Modulates Tomato Root Morphology by Regulating Key Genes and Endogenous Hormones
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Myeloproliferative disorder associated with alopecia universalis
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Alopecia Areata Is Associated with an Increased Risk for Prediabetes and Obesity: A Nationwide Case—Control Study
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Interleukin-6 Null Mice Paradoxically Display Increased STAT3 Activity and Wound-Induced Hair Neogenesis
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- N,N-Dimethylglycine Sodium Salt Exerts Marked Anti-Inflammatory Effects in Various Dermatitis Models and Activates Human Epidermal Keratinocytes by Increasing Proliferation, Migration, and Growth Factor Release